Wheezing clinical trials at UCSF
2 in progress, 1 open to eligible people
Wheezing is a sound made when air moves through narrowed airways. UCSF is conducting research to evaluate a daily treatment called OM-85 for children with recurring wheezing. The trial aims to determine the safety and effectiveness of this treatment compared to a placebo.
Daily OM-85 in Young Children With Recurrent Wheezing
open to eligible people ages 6 months to 72 months
This study will assess the efficacy and safety of daily OM-85 treatment compared to placebo in children aged 6 months to 5 years with recurrent wheezing
Oakland, California and other locations
Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness
Sorry, in progress, not accepting new patients
The primary objective of this study is to evaluate if Broncho-Vaxom® given to high risk infants for 10 days, monthly, for two consecutive years can increase time to occurrence of the first episode of wheezing lower respiratory tract illness (WLRI) during a three year observation period off therapy.
Oakland, California and other locations
Last updated: